Stroke
RSSArticles
-
Emergency Medicine Reports - Full June 20, 2011 Issue in Streaming Audio/Downloadable MP3 Format
-
NSAID use in patients with prior MI
A new study points out the risk of nonsteroidal anti-inflammatory drug (NSAID) use in patients who have had a myocardial infarction (MI) suggesting that even brief use increases the risk for death and recurrent MI. -
FDA actions
The FDA has approved linagliptin for the treatment of type 2 diabetes in adults. -
Two new drugs for hepatitis C
The FDA has approved two new drugs for the treatment of hepatitis C the first new drugs to be approved in years. -
NHLBI stops AIM-HIGH trial
Niacin may not be effective in preventing cardiovascular disease. -
Bacterial Meningitis: Rarer, in Older Patients, but Equally Deadly
With the advent of new vaccines, the incidence of bacterial meningitis has declined, particularly in children, but the mortality rate has remained the same. -
Variant Creutzfeldt-Jakob Disease: A Review of 150 Cases
Variant Creutzfeldt-Jakob disease usually presents with subtle psychiatric symptoms and there is usually a significant delay in diagnosis. -
Are We Close to Understanding the Role of Fingolimod in the Treatment of MS?
Patients originally on interferon beta-1a in the TRANSFORMS study were re-randomized to either 0.5 or 1.25 mg of fingolimod. There was a reduction in relapse rate and MRI activity in patients that switched to fingolimod without an increase in severe adverse events. -
Clinical Briefs in Primary Care Supplement
-
REM Sleep Behavior Disorder and Biomarkers of Neurodegenerative Disease
Biomarkers for Parkinson's disease and related neurodegenerative diseases occur frequently in patients with idiopathic REM sleep behavior disorder. These include impairment of olfactory and color discrimination, and abnormalities in cerebral blood flow.